IVCVQMAug 3, 2023

Predicting Ki67, ER, PR, and HER2 Statuses from H&E-stained Breast Cancer Images

arXiv:2308.01982v117 citationsh-index: 32
Originality Synthesis-oriented
AI Analysis

This addresses the problem of predicting molecular biomarkers from histopathology for breast cancer diagnosis, but it is incremental as it applies an existing method to new data.

The study tackled whether machine learning can predict molecular statuses (Ki67, ER, PR, HER2) from H&E-stained breast cancer images, achieving around 90% AUC using a standard ViT-based pipeline on a large-scale dataset of 185,538 images.

Despite the advances in machine learning and digital pathology, it is not yet clear if machine learning methods can accurately predict molecular information merely from histomorphology. In a quest to answer this question, we built a large-scale dataset (185538 images) with reliable measurements for Ki67, ER, PR, and HER2 statuses. The dataset is composed of mirrored images of H\&E and corresponding images of immunohistochemistry (IHC) assays (Ki67, ER, PR, and HER2. These images are mirrored through registration. To increase reliability, individual pairs were inspected and discarded if artifacts were present (tissue folding, bubbles, etc). Measurements for Ki67, ER and PR were determined by calculating H-Score from image analysis. HER2 measurement is based on binary classification: 0 and 1+ (IHC scores representing a negative subset) vs 3+ (IHC score positive subset). Cases with IHC equivocal score (2+) were excluded. We show that a standard ViT-based pipeline can achieve prediction performances around 90% in terms of Area Under the Curve (AUC) when trained with a proper labeling protocol. Finally, we shed light on the ability of the trained classifiers to localize relevant regions, which encourages future work to improve the localizations. Our proposed dataset is publicly available: https://ihc4bc.github.io/

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes